Mark R. Battig

ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor

Dong Li, Michael March, Álvaro Gutiérrez-Uzquiza et al. · Nature Medicine · 2019 · 219 citations

Medicine, Cell Biology, Molecular Medicine +11

Programmable Hydrogels for Controlled Cell Catch and Release Using Hybridized Aptamers and Complementary Sequences

Zhaoyang Zhang, Niancao Chen, Shihui Li et al. · Journal of the American Chemical Society · 2012 · 137 citations

Engineering, Bioengineering, Biotechnology +15

Programmable Release of Multiple Protein Drugs from Aptamer-Functionalized Hydrogels via Nucleic Acid Hybridization

Mark R. Battig, Boonchoy Soontornworajit, Yong Wang · Journal of the American Chemical Society · 2012 · 133 citations

Pharmacy, Pharmaceutical Biotechnology, Pharmaceutics +17

Aptamer-functionalized superporous hydrogels for sequestration and release of growth factors regulated via molecular recognition

Mark R. Battig, Yike Huang, Niancao Chen et al. · Biomaterials · 2014 · 66 citations

Engineering, Bioengineering, Biomedical Engineering +16

Genomic profiling informs diagnoses and treatment in vascular anomalies

Dong Li, Sarah E. Sheppard, Michael March et al. · Nature Medicine · 2023 · 62 citations · Full text

Medicine, Genetics, Molecular Genetics +14